---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-004671"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:17:43.566622+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# VolitionRx raises $7M in registered direct offering with milestone-linked warrants for up to $14.5M additional

## Summary
- Gross proceeds of ~$7M from sale of 12.7M shares/pre-funded warrants at $0.55 each; warrants exercisable at $0.57.
- Series A warrants expire 60 days after announcement of $10M+ milestone commercial agreements; series B expire 6 months after first FDA approval.
- Potential additional $14.5M if all milestone-linked warrants exercised on cash basis; no assurance of exercise.
- Net proceeds earmarked for R&D, clinical studies, product commercialization, working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001477932-24-004671
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793224004671/0001477932-24-004671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793224004671/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-004671
- JSON: https://secwatch.observer/filing/0001477932-24-004671.json
- Plain text: https://secwatch.observer/filing/0001477932-24-004671.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.